Filtered By:
Vaccination: Cervical Cancer Vaccine
This page shows you your search results in order of relevance. This is page number 19.
Order by Relevance | Date
Total 4070 results found since Jan 2013.
Screening for cervical cancer: Choices & amp; dilemmas
Indian J Med Res. 2021 Dec 2. doi: 10.4103/ijmr.IJMR_857_20. Online ahead of print.ABSTRACTCervical cancer is the fourth most common cancer in women in the world. To eliminate cervical cancer by 2030, the World Health Organization has given the target of 70 per cent coverage of twice lifetime screening. A multitude of screening methods are available, including cytology, human papillomavirus (HPV) DNA testing and visual inspection tests. Precision tests, including molecular and protein biomarkers such as DNA methylation, p16 immunostaining, and HPV mRNA testing help to enhance specificity of the screening. Worldwide HPV DNA...
Source: The Indian Journal of Medical Research - December 2, 2021 Category: Biomedical Science Authors: Shalini Rajaram Bindiya Gupta Source Type: research
When and How Would You Screen This Patient for Cervical Cancer? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center
Ann Intern Med. 2022 Feb 8. doi: 10.7326/M21-4372. Online ahead of print.ABSTRACTSuccessful screening programs based on cervical cytology have dramatically reduced the incidence of cervical cancer in the United States. Human papillomavirus immunization is poised to reduce it further as an increasing percentage of vaccinated women reach adulthood. A recent guideline from the American Cancer Society advises that cervical cancer screening begin at age 25 and that high-risk human papillomavirus testing is the preferred screening test. The U.S. Preventive Services Task Force recommends screening begin at age 21 and that cytolog...
Source: Annals of Internal Medicine - February 7, 2022 Category: Internal Medicine Authors: Eileen E Reynolds Amy Weinstein Huma Farid Howard Libman Source Type: research
Screening for cervical cancer: Choices & amp; dilemmas
Indian J Med Res. 2021 Dec 2. doi: 10.4103/ijmr.IJMR_857_20. Online ahead of print.ABSTRACTCervical cancer is the fourth most common cancer in women in the world. To eliminate cervical cancer by 2030, the World Health Organization has given the target of 70 per cent coverage of twice lifetime screening. A multitude of screening methods are available, including cytology, human papillomavirus (HPV) DNA testing and visual inspection tests. Precision tests, including molecular and protein biomarkers such as DNA methylation, p16 immunostaining, and HPV mRNA testing help to enhance specificity of the screening. Worldwide HPV DNA...
Source: The Indian Journal of Medical Research - December 2, 2021 Category: Biomedical Science Authors: Shalini Rajaram Bindiya Gupta Source Type: research
When and How Would You Screen This Patient for Cervical Cancer? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center
Ann Intern Med. 2022 Feb 8. doi: 10.7326/M21-4372. Online ahead of print.ABSTRACTSuccessful screening programs based on cervical cytology have dramatically reduced the incidence of cervical cancer in the United States. Human papillomavirus immunization is poised to reduce it further as an increasing percentage of vaccinated women reach adulthood. A recent guideline from the American Cancer Society advises that cervical cancer screening begin at age 25 and that high-risk human papillomavirus testing is the preferred screening test. The U.S. Preventive Services Task Force recommends screening begin at age 21 and that cytolog...
Source: Annals of Internal Medicine - February 7, 2022 Category: Internal Medicine Authors: Eileen E Reynolds Amy Weinstein Huma Farid Howard Libman Source Type: research
Screening for cervical cancer: Choices & amp; dilemmas
Indian J Med Res. 2021 Dec 2. doi: 10.4103/ijmr.IJMR_857_20. Online ahead of print.ABSTRACTCervical cancer is the fourth most common cancer in women in the world. To eliminate cervical cancer by 2030, the World Health Organization has given the target of 70 per cent coverage of twice lifetime screening. A multitude of screening methods are available, including cytology, human papillomavirus (HPV) DNA testing and visual inspection tests. Precision tests, including molecular and protein biomarkers such as DNA methylation, p16 immunostaining, and HPV mRNA testing help to enhance specificity of the screening. Worldwide HPV DNA...
Source: The Indian Journal of Medical Research - December 2, 2021 Category: Biomedical Science Authors: Shalini Rajaram Bindiya Gupta Source Type: research
When and How Would You Screen This Patient for Cervical Cancer? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center
Ann Intern Med. 2022 Feb 8. doi: 10.7326/M21-4372. Online ahead of print.ABSTRACTSuccessful screening programs based on cervical cytology have dramatically reduced the incidence of cervical cancer in the United States. Human papillomavirus immunization is poised to reduce it further as an increasing percentage of vaccinated women reach adulthood. A recent guideline from the American Cancer Society advises that cervical cancer screening begin at age 25 and that high-risk human papillomavirus testing is the preferred screening test. The U.S. Preventive Services Task Force recommends screening begin at age 21 and that cytolog...
Source: Annals of Internal Medicine - February 7, 2022 Category: Internal Medicine Authors: Eileen E Reynolds Amy Weinstein Huma Farid Howard Libman Source Type: research
Screening for cervical cancer: Choices & amp; dilemmas
Indian J Med Res. 2021 Dec 2. doi: 10.4103/ijmr.IJMR_857_20. Online ahead of print.ABSTRACTCervical cancer is the fourth most common cancer in women in the world. To eliminate cervical cancer by 2030, the World Health Organization has given the target of 70 per cent coverage of twice lifetime screening. A multitude of screening methods are available, including cytology, human papillomavirus (HPV) DNA testing and visual inspection tests. Precision tests, including molecular and protein biomarkers such as DNA methylation, p16 immunostaining, and HPV mRNA testing help to enhance specificity of the screening. Worldwide HPV DNA...
Source: The Indian Journal of Medical Research - December 2, 2021 Category: Biomedical Science Authors: Shalini Rajaram Bindiya Gupta Source Type: research
When and How Would You Screen This Patient for Cervical Cancer? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center
Ann Intern Med. 2022 Feb 8. doi: 10.7326/M21-4372. Online ahead of print.ABSTRACTSuccessful screening programs based on cervical cytology have dramatically reduced the incidence of cervical cancer in the United States. Human papillomavirus immunization is poised to reduce it further as an increasing percentage of vaccinated women reach adulthood. A recent guideline from the American Cancer Society advises that cervical cancer screening begin at age 25 and that high-risk human papillomavirus testing is the preferred screening test. The U.S. Preventive Services Task Force recommends screening begin at age 21 and that cytolog...
Source: Annals of Internal Medicine - February 7, 2022 Category: Internal Medicine Authors: Eileen E Reynolds Amy Weinstein Huma Farid Howard Libman Source Type: research
Relationship between awareness of cervical cancer and HPV infection and attitudes towards HPV vaccine among women aged 15-49 years: a cross-sectional study
CONCLUSION: Women need information about cervical cancer, HPV infection and the HPV vaccine. Midwives, nurses and physicians who provide healthcare services in gynecological follow-ups should provide information to women about the HPV vaccine and cervical cancer.PMID:35507990 | DOI:10.1590/1516-3180.2021.0145.27072021
Source: Sao Paulo Medical Journal - May 4, 2022 Category: General Medicine Authors: Engin Yurt çu Reyhan Ayd ın Doğan B üşra Karaaslan Sibel Mutlu Source Type: research
